SEMA4D and acute respiratory distress syndrome: AS exerts therapeutic effect in ALI by promoting miRNA-21 expression, inhibiting the Sema4D/CD72/NF-κB signaling pathway and mitochondrial dysfunction, decreasing apoptosis, and restoring the balance of inflammatory mediators.